Research Insight
Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes, India
Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of hypertriglyceridemia in Type II diabetics. The drug was discovered and...
Research Insight
Trophos will present results of pivotal phase II/III study of olesoxime in spinal muscular atrophy patients at the American Academy of Neurology
Trophos and AFM-Telethon (The French Muscular Dystrophy Association) today announce that data from the pivotal clinical trial of Trophos’ lead product candidate olesoxime in spinal...
Research Insight
Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone(R) Lispro
Adocia (Euronext Paris: FR0011184241 - ADOC) announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison...
Research Insight
Body kills ‘spontaneous’ blood cancers on a daily basis
Immune cells undergo 'spontaneous' changes on a daily basis that could lead to cancers if not for the diligent surveillance of our immune system, Melbourne...
Research Insight
Oramed releases Phase IIa trial of ORMD-0801 to treat type 2 diabetes
Oramed Pharmaceuticals has released results of a Phase IIa clinical trial of its ORMD-0801, an oral insulin capsule for the treatment of...
Research Insight
Immuneering Corporation Expands Alliance with Bristol-Myers Squibb
Immuneering Corporation announced today that it has entered into an agreement to expand its existing relationship with Bristol-Myers Squibb for the use...
Research Insight
IMI Builds Collaborations to Monitor Vaccine Safety and Drug Effectiveness
The Innovative Medicines Initiative (IMI) is calling experts to join forces and tackle two challenges which are of major importance to public health. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.